193 related articles for article (PubMed ID: 35295055)
21. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
[TBL] [Abstract][Full Text] [Related]
22. Distribution of intestinal metaplasia as a predictor of gastric cancer development.
Shichijo S; Hirata Y; Sakitani K; Yamamoto S; Serizawa T; Niikura R; Watabe H; Yoshida S; Yamada A; Yamaji Y; Ushiku T; Fukayama M; Koike K
J Gastroenterol Hepatol; 2015 Aug; 30(8):1260-4. PubMed ID: 25777777
[TBL] [Abstract][Full Text] [Related]
23. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
24. Role of endoscopy in suspicion of atrophic gastritis with and without intestinal metaplasia in comparison to histopathology.
Ibrahim H; El-Deen AS; Kasemy ZA; Saad M; Sakr AA
Acta Gastroenterol Belg; 2021; 84(1):9-17. PubMed ID: 33639688
[TBL] [Abstract][Full Text] [Related]
25. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
26. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication.
Morales TG; Sampliner RE; Camargo E; Marquis S; Garewal HS; Fennerty MB
J Clin Gastroenterol; 2001; 32(5):400-4. PubMed ID: 11319310
[TBL] [Abstract][Full Text] [Related]
27. Pathological disorders of the gastric mucosa surrounding carcinomas and primary lymphomas.
Arista-Nasr J; Jiménez-Rosas F; Uribe-Uribe N; Herrera-Goepfert R; Lazos-Ochoa M
Am J Gastroenterol; 2001 Jun; 96(6):1746-50. PubMed ID: 11419824
[TBL] [Abstract][Full Text] [Related]
28. Risks and Predictors of Gastric Adenocarcinoma in Patients with Gastric Intestinal Metaplasia and Dysplasia: A Population-Based Study.
Li D; Bautista MC; Jiang SF; Daryani P; Brackett M; Armstrong MA; Hung YY; Postlethwaite D; Ladabaum U
Am J Gastroenterol; 2016 Aug; 111(8):1104-13. PubMed ID: 27185078
[TBL] [Abstract][Full Text] [Related]
29. Antral-type mucosa in the gastric incisura, body, and fundus (antralization): a link between Helicobacter pylori infection and intestinal metaplasia?
Xia HH; Kalantar JS; Talley NJ; Wyatt JM; Adams S; Chueng K; Mitchell HM
Am J Gastroenterol; 2000 Jan; 95(1):114-21. PubMed ID: 10638568
[TBL] [Abstract][Full Text] [Related]
30. Gastric Antral Mucosal Changes in Children With Intestinal Metaplasia.
Li G; Kelly DR; Mroczek-Musulman E; Wang K; Council L; Zhao L
Pediatr Dev Pathol; 2022; 25(5):511-517. PubMed ID: 35510382
[No Abstract] [Full Text] [Related]
31. Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Shichijo S; Hirata Y; Niikura R; Hayakawa Y; Yamada A; Ushiku T; Fukayama M; Koike K
Gastrointest Endosc; 2016 Oct; 84(4):618-24. PubMed ID: 26995689
[TBL] [Abstract][Full Text] [Related]
32. Long-term course of precancerous lesions arising in patients with gastric MALT lymphoma.
Rentien AL; Lévy M; Copie-Bergman C; Gagniere C; Dupuis J; Le Baleur Y; Belhadj K; Sobhani I; Haioun C; Delchier JC; Amiot A
Dig Liver Dis; 2018 Feb; 50(2):181-188. PubMed ID: 29102522
[TBL] [Abstract][Full Text] [Related]
33. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M
Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867
[TBL] [Abstract][Full Text] [Related]
34. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis.
Petersson F; Borch K; Franzén LE
Scand J Gastroenterol; 2002 Mar; 37(3):262-6. PubMed ID: 11916187
[TBL] [Abstract][Full Text] [Related]
36. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration.
Sakitani K; Hirata Y; Watabe H; Yamada A; Sugimoto T; Yamaji Y; Yoshida H; Maeda S; Omata M; Koike K
J Gastroenterol Hepatol; 2011 Oct; 26(10):1570-5. PubMed ID: 21575058
[TBL] [Abstract][Full Text] [Related]
37. Risk of gastric cancer in children with Helicobacter pylori infection.
Cam S
Asian Pac J Cancer Prev; 2014; 15(22):9905-8. PubMed ID: 25520126
[TBL] [Abstract][Full Text] [Related]
38. Does Helicobacter pylori eradication modify intestinal metaplasia evolution in the stomach?
Ravizza M
Minerva Gastroenterol Dietol; 2002 Jun; 48(2):165-7. PubMed ID: 16489310
[TBL] [Abstract][Full Text] [Related]
39. Helicobacter PyloriAssociation with Expression of CDX2 in Intestinal Metaplasia.
Malik TH; WangYu ; XuHong
J Coll Physicians Surg Pak; 2017 Nov; 27(11):678-681. PubMed ID: 29132476
[TBL] [Abstract][Full Text] [Related]
40. Precancerous gastric lesions and Helicobacter pylori.
Masci E; Viale E; Freschi M; Porcellati M; Tittobello A
Hepatogastroenterology; 1996; 43(10):854-8. PubMed ID: 8884303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
